0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Rare Genetic Disease Diagnosis Solution Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17L15214
Home | Market Reports | Health| Health Conditions| Genetic Disorders
Global Rare Genetic Disease Diagnosis Solution Market Research Report 2023
BUY CHAPTERS

Global Rare Genetic Disease Diagnosis Solution Market Research Report 2025

Code: QYRE-Auto-17L15214
Report
May 2025
Pages:79
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Rare Genetic Disease Diagnosis Solution Market

The global market for Rare Genetic Disease Diagnosis Solution was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Rare genetic disease diagnosis solution refers to the process and tools used to diagnose rare genetic diseases. Rare genetic diseases are caused by variations or mutations in genes and often have a low prevalence in the population. Due to their rarity and complexity, diagnosing these diseases can be challenging and require specialized approaches.
North American market for Rare Genetic Disease Diagnosis Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
Asia-Pacific market for Rare Genetic Disease Diagnosis Solution is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The global market for Rare Genetic Disease Diagnosis Solution in Clinical Genetics and Pediatric Clinic is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.
The major global companies of Rare Genetic Disease Diagnosis Solution include Retrophin, 3billion, 23andMe, Ancestry, GeneDx, Ambry Genetics, QIAGEN, Illumina, PerkinElmer, Strand Life Sciences, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Rare Genetic Disease Diagnosis Solution, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Rare Genetic Disease Diagnosis Solution.
The Rare Genetic Disease Diagnosis Solution market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Rare Genetic Disease Diagnosis Solution market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Rare Genetic Disease Diagnosis Solution companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Rare Genetic Disease Diagnosis Solution Market Report

Report Metric Details
Report Name Rare Genetic Disease Diagnosis Solution Market
Segment by Type
Segment by Application
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Retrophin, 3billion, 23andMe, Ancestry, GeneDx, Ambry Genetics, QIAGEN, Illumina, PerkinElmer, Strand Life Sciences
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Rare Genetic Disease Diagnosis Solution company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Rare Genetic Disease Diagnosis Solution Market report?

Ans: The main players in the Rare Genetic Disease Diagnosis Solution Market are Retrophin, 3billion, 23andMe, Ancestry, GeneDx, Ambry Genetics, QIAGEN, Illumina, PerkinElmer, Strand Life Sciences

What are the Application segmentation covered in the Rare Genetic Disease Diagnosis Solution Market report?

Ans: The Applications covered in the Rare Genetic Disease Diagnosis Solution Market report are Clinical Genetics and Pediatric Clinic, Newborn Screening Program, Research and Development, Others

What are the Type segmentation covered in the Rare Genetic Disease Diagnosis Solution Market report?

Ans: The Types covered in the Rare Genetic Disease Diagnosis Solution Market report are Genetic Testing, Biochemical Testing, Imaging and Diagnostic Procedures, Others

Recommended Reports

Genetic Testing Solutions

Rare Disease Diagnosis

Molecular & Genomic Medicine

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Genetic Testing
1.2.3 Biochemical Testing
1.2.4 Imaging and Diagnostic Procedures
1.2.5 Others
1.3 Market by Application
1.3.1 Global Rare Genetic Disease Diagnosis Solution Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Clinical Genetics and Pediatric Clinic
1.3.3 Newborn Screening Program
1.3.4 Research and Development
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Rare Genetic Disease Diagnosis Solution Market Perspective (2020-2031)
2.2 Global Rare Genetic Disease Diagnosis Solution Growth Trends by Region
2.2.1 Global Rare Genetic Disease Diagnosis Solution Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Rare Genetic Disease Diagnosis Solution Historic Market Size by Region (2020-2025)
2.2.3 Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Region (2026-2031)
2.3 Rare Genetic Disease Diagnosis Solution Market Dynamics
2.3.1 Rare Genetic Disease Diagnosis Solution Industry Trends
2.3.2 Rare Genetic Disease Diagnosis Solution Market Drivers
2.3.3 Rare Genetic Disease Diagnosis Solution Market Challenges
2.3.4 Rare Genetic Disease Diagnosis Solution Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Rare Genetic Disease Diagnosis Solution Players by Revenue
3.1.1 Global Top Rare Genetic Disease Diagnosis Solution Players by Revenue (2020-2025)
3.1.2 Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Players (2020-2025)
3.2 Global Rare Genetic Disease Diagnosis Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Rare Genetic Disease Diagnosis Solution Revenue
3.4 Global Rare Genetic Disease Diagnosis Solution Market Concentration Ratio
3.4.1 Global Rare Genetic Disease Diagnosis Solution Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Rare Genetic Disease Diagnosis Solution Revenue in 2024
3.5 Global Key Players of Rare Genetic Disease Diagnosis Solution Head office and Area Served
3.6 Global Key Players of Rare Genetic Disease Diagnosis Solution, Product and Application
3.7 Global Key Players of Rare Genetic Disease Diagnosis Solution, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Rare Genetic Disease Diagnosis Solution Breakdown Data by Type
4.1 Global Rare Genetic Disease Diagnosis Solution Historic Market Size by Type (2020-2025)
4.2 Global Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Type (2026-2031)
5 Rare Genetic Disease Diagnosis Solution Breakdown Data by Application
5.1 Global Rare Genetic Disease Diagnosis Solution Historic Market Size by Application (2020-2025)
5.2 Global Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Rare Genetic Disease Diagnosis Solution Market Size (2020-2031)
6.2 North America Rare Genetic Disease Diagnosis Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2020-2025)
6.4 North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Rare Genetic Disease Diagnosis Solution Market Size (2020-2031)
7.2 Europe Rare Genetic Disease Diagnosis Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2020-2025)
7.4 Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size (2020-2031)
8.2 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Region (2020-2025)
8.4 Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Rare Genetic Disease Diagnosis Solution Market Size (2020-2031)
9.2 Latin America Rare Genetic Disease Diagnosis Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Rare Genetic Disease Diagnosis Solution Market Size by Country (2020-2025)
9.4 Latin America Rare Genetic Disease Diagnosis Solution Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size (2020-2031)
10.2 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2020-2025)
10.4 Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Retrophin
11.1.1 Retrophin Company Details
11.1.2 Retrophin Business Overview
11.1.3 Retrophin Rare Genetic Disease Diagnosis Solution Introduction
11.1.4 Retrophin Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.1.5 Retrophin Recent Development
11.2 3billion
11.2.1 3billion Company Details
11.2.2 3billion Business Overview
11.2.3 3billion Rare Genetic Disease Diagnosis Solution Introduction
11.2.4 3billion Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.2.5 3billion Recent Development
11.3 23andMe
11.3.1 23andMe Company Details
11.3.2 23andMe Business Overview
11.3.3 23andMe Rare Genetic Disease Diagnosis Solution Introduction
11.3.4 23andMe Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.3.5 23andMe Recent Development
11.4 Ancestry
11.4.1 Ancestry Company Details
11.4.2 Ancestry Business Overview
11.4.3 Ancestry Rare Genetic Disease Diagnosis Solution Introduction
11.4.4 Ancestry Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.4.5 Ancestry Recent Development
11.5 GeneDx
11.5.1 GeneDx Company Details
11.5.2 GeneDx Business Overview
11.5.3 GeneDx Rare Genetic Disease Diagnosis Solution Introduction
11.5.4 GeneDx Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.5.5 GeneDx Recent Development
11.6 Ambry Genetics
11.6.1 Ambry Genetics Company Details
11.6.2 Ambry Genetics Business Overview
11.6.3 Ambry Genetics Rare Genetic Disease Diagnosis Solution Introduction
11.6.4 Ambry Genetics Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.6.5 Ambry Genetics Recent Development
11.7 QIAGEN
11.7.1 QIAGEN Company Details
11.7.2 QIAGEN Business Overview
11.7.3 QIAGEN Rare Genetic Disease Diagnosis Solution Introduction
11.7.4 QIAGEN Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.7.5 QIAGEN Recent Development
11.8 Illumina
11.8.1 Illumina Company Details
11.8.2 Illumina Business Overview
11.8.3 Illumina Rare Genetic Disease Diagnosis Solution Introduction
11.8.4 Illumina Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.8.5 Illumina Recent Development
11.9 PerkinElmer
11.9.1 PerkinElmer Company Details
11.9.2 PerkinElmer Business Overview
11.9.3 PerkinElmer Rare Genetic Disease Diagnosis Solution Introduction
11.9.4 PerkinElmer Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.9.5 PerkinElmer Recent Development
11.10 Strand Life Sciences
11.10.1 Strand Life Sciences Company Details
11.10.2 Strand Life Sciences Business Overview
11.10.3 Strand Life Sciences Rare Genetic Disease Diagnosis Solution Introduction
11.10.4 Strand Life Sciences Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
11.10.5 Strand Life Sciences Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Genetic Testing
 Table 3. Key Players of Biochemical Testing
 Table 4. Key Players of Imaging and Diagnostic Procedures
 Table 5. Key Players of Others
 Table 6. Global Rare Genetic Disease Diagnosis Solution Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Rare Genetic Disease Diagnosis Solution Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 8. Global Rare Genetic Disease Diagnosis Solution Market Size by Region (2020-2025) & (US$ Million)
 Table 9. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2020-2025)
 Table 10. Global Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 11. Global Rare Genetic Disease Diagnosis Solution Market Share by Region (2026-2031)
 Table 12. Rare Genetic Disease Diagnosis Solution Market Trends
 Table 13. Rare Genetic Disease Diagnosis Solution Market Drivers
 Table 14. Rare Genetic Disease Diagnosis Solution Market Challenges
 Table 15. Rare Genetic Disease Diagnosis Solution Market Restraints
 Table 16. Global Rare Genetic Disease Diagnosis Solution Revenue by Players (2020-2025) & (US$ Million)
 Table 17. Global Rare Genetic Disease Diagnosis Solution Market Share by Players (2020-2025)
 Table 18. Global Top Rare Genetic Disease Diagnosis Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Genetic Disease Diagnosis Solution as of 2024)
 Table 19. Ranking of Global Top Rare Genetic Disease Diagnosis Solution Companies by Revenue (US$ Million) in 2024
 Table 20. Global 5 Largest Players Market Share by Rare Genetic Disease Diagnosis Solution Revenue (CR5 and HHI) & (2020-2025)
 Table 21. Global Key Players of Rare Genetic Disease Diagnosis Solution, Headquarters and Area Served
 Table 22. Global Key Players of Rare Genetic Disease Diagnosis Solution, Product and Application
 Table 23. Global Key Players of Rare Genetic Disease Diagnosis Solution, Date of Enter into This Industry
 Table 24. Mergers & Acquisitions, Expansion Plans
 Table 25. Global Rare Genetic Disease Diagnosis Solution Market Size by Type (2020-2025) & (US$ Million)
 Table 26. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2020-2025)
 Table 27. Global Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 28. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Type (2026-2031)
 Table 29. Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2020-2025) & (US$ Million)
 Table 30. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2020-2025)
 Table 31. Global Rare Genetic Disease Diagnosis Solution Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 32. Global Rare Genetic Disease Diagnosis Solution Revenue Market Share by Application (2026-2031)
 Table 33. North America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 34. North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 35. North America Rare Genetic Disease Diagnosis Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 36. Europe Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 37. Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 38. Europe Rare Genetic Disease Diagnosis Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 39. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 40. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Region (2020-2025) & (US$ Million)
 Table 41. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size by Region (2026-2031) & (US$ Million)
 Table 42. Latin America Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 43. Latin America Rare Genetic Disease Diagnosis Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Rare Genetic Disease Diagnosis Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 45. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 46. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2020-2025) & (US$ Million)
 Table 47. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size by Country (2026-2031) & (US$ Million)
 Table 48. Retrophin Company Details
 Table 49. Retrophin Business Overview
 Table 50. Retrophin Rare Genetic Disease Diagnosis Solution Product
 Table 51. Retrophin Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 52. Retrophin Recent Development
 Table 53. 3billion Company Details
 Table 54. 3billion Business Overview
 Table 55. 3billion Rare Genetic Disease Diagnosis Solution Product
 Table 56. 3billion Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 57. 3billion Recent Development
 Table 58. 23andMe Company Details
 Table 59. 23andMe Business Overview
 Table 60. 23andMe Rare Genetic Disease Diagnosis Solution Product
 Table 61. 23andMe Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 62. 23andMe Recent Development
 Table 63. Ancestry Company Details
 Table 64. Ancestry Business Overview
 Table 65. Ancestry Rare Genetic Disease Diagnosis Solution Product
 Table 66. Ancestry Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 67. Ancestry Recent Development
 Table 68. GeneDx Company Details
 Table 69. GeneDx Business Overview
 Table 70. GeneDx Rare Genetic Disease Diagnosis Solution Product
 Table 71. GeneDx Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 72. GeneDx Recent Development
 Table 73. Ambry Genetics Company Details
 Table 74. Ambry Genetics Business Overview
 Table 75. Ambry Genetics Rare Genetic Disease Diagnosis Solution Product
 Table 76. Ambry Genetics Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 77. Ambry Genetics Recent Development
 Table 78. QIAGEN Company Details
 Table 79. QIAGEN Business Overview
 Table 80. QIAGEN Rare Genetic Disease Diagnosis Solution Product
 Table 81. QIAGEN Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 82. QIAGEN Recent Development
 Table 83. Illumina Company Details
 Table 84. Illumina Business Overview
 Table 85. Illumina Rare Genetic Disease Diagnosis Solution Product
 Table 86. Illumina Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 87. Illumina Recent Development
 Table 88. PerkinElmer Company Details
 Table 89. PerkinElmer Business Overview
 Table 90. PerkinElmer Rare Genetic Disease Diagnosis Solution Product
 Table 91. PerkinElmer Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 92. PerkinElmer Recent Development
 Table 93. Strand Life Sciences Company Details
 Table 94. Strand Life Sciences Business Overview
 Table 95. Strand Life Sciences Rare Genetic Disease Diagnosis Solution Product
 Table 96. Strand Life Sciences Revenue in Rare Genetic Disease Diagnosis Solution Business (2020-2025) & (US$ Million)
 Table 97. Strand Life Sciences Recent Development
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Rare Genetic Disease Diagnosis Solution Picture
 Figure 2. Global Rare Genetic Disease Diagnosis Solution Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Rare Genetic Disease Diagnosis Solution Market Share by Type: 2024 VS 2031
 Figure 4. Genetic Testing Features
 Figure 5. Biochemical Testing Features
 Figure 6. Imaging and Diagnostic Procedures Features
 Figure 7. Others Features
 Figure 8. Global Rare Genetic Disease Diagnosis Solution Market Size by Application (2020-2031) & (US$ Million)
 Figure 9. Global Rare Genetic Disease Diagnosis Solution Market Share by Application: 2024 VS 2031
 Figure 10. Clinical Genetics and Pediatric Clinic Case Studies
 Figure 11. Newborn Screening Program Case Studies
 Figure 12. Research and Development Case Studies
 Figure 13. Others Case Studies
 Figure 14. Rare Genetic Disease Diagnosis Solution Report Years Considered
 Figure 15. Global Rare Genetic Disease Diagnosis Solution Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 16. Global Rare Genetic Disease Diagnosis Solution Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 17. Global Rare Genetic Disease Diagnosis Solution Market Share by Region: 2024 VS 2031
 Figure 18. Global Rare Genetic Disease Diagnosis Solution Market Share by Players in 2024
 Figure 19. Global Top Rare Genetic Disease Diagnosis Solution Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Rare Genetic Disease Diagnosis Solution as of 2024)
 Figure 20. The Top 10 and 5 Players Market Share by Rare Genetic Disease Diagnosis Solution Revenue in 2024
 Figure 21. North America Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 22. North America Rare Genetic Disease Diagnosis Solution Market Share by Country (2020-2031)
 Figure 23. United States Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Canada Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 26. Europe Rare Genetic Disease Diagnosis Solution Market Share by Country (2020-2031)
 Figure 27. Germany Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. France Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. U.K. Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Italy Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Russia Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Nordic Countries Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 34. Asia-Pacific Rare Genetic Disease Diagnosis Solution Market Share by Region (2020-2031)
 Figure 35. China Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. Japan Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. South Korea Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. Southeast Asia Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. India Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Australia Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 42. Latin America Rare Genetic Disease Diagnosis Solution Market Share by Country (2020-2031)
 Figure 43. Mexico Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Brazil Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 46. Middle East & Africa Rare Genetic Disease Diagnosis Solution Market Share by Country (2020-2031)
 Figure 47. Turkey Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. Saudi Arabia Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. UAE Rare Genetic Disease Diagnosis Solution Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 50. Retrophin Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 51. 3billion Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 52. 23andMe Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 53. Ancestry Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 54. GeneDx Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 55. Ambry Genetics Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 56. QIAGEN Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 57. Illumina Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 58. PerkinElmer Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 59. Strand Life Sciences Revenue Growth Rate in Rare Genetic Disease Diagnosis Solution Business (2020-2025)
 Figure 60. Bottom-up and Top-down Approaches for This Report
 Figure 61. Data Triangulation
 Figure 62. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

SIS Group of Schools

RELATED REPORTS

Global Cystic Fibrosis (Mucoviscoidosis) Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-24R5886
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Lysosomal Storage Diseases Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34Q5936
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Acute Intermittent Porphyria Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-6U7336
Mon Sep 08 00:00:00 UTC 2025

Add to Cart

Global Phenylketonuria Treatment Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-12R6229
Mon Sep 08 00:00:00 UTC 2025

Add to Cart